ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 115 filers reported holding ANAPTYSBIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,209,952 | -52.1% | 791,200 | -45.8% | 0.04% | -53.4% |
| Q2 2023 | $29,694,549 | -18.8% | 1,459,909 | -13.2% | 0.09% | -22.1% |
| Q1 2023 | $36,581,759 | -44.4% | 1,681,147 | -20.9% | 0.11% | -49.6% |
| Q4 2022 | $65,828,958 | +2.2% | 2,124,200 | -15.9% | 0.22% | -12.8% |
| Q3 2022 | $64,443,000 | +272.7% | 2,526,200 | +196.6% | 0.26% | +252.1% |
| Q2 2022 | $17,292,000 | -47.0% | 851,800 | -35.4% | 0.07% | -43.4% |
| Q1 2022 | $32,597,000 | +264.8% | 1,317,600 | +412.4% | 0.13% | +258.3% |
| Q4 2021 | $8,936,000 | -45.3% | 257,145 | -66.2% | 0.04% | -55.0% |
| Q4 2020 | $16,346,000 | +247.0% | 760,300 | +260.5% | 0.08% | +158.1% |
| Q2 2020 | $4,711,000 | +1019.0% | 210,886 | +714.2% | 0.03% | +1450.0% |
| Q4 2019 | $421,000 | -82.8% | 25,900 | -22.9% | 0.00% | -81.8% |
| Q1 2019 | $2,454,000 | +23.0% | 33,600 | +68.0% | 0.01% | +37.5% |
| Q3 2018 | $1,995,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
| EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
| Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
| GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
| 5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
| First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
| Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
| Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
| Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
| Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |